Search Results

You are looking at 1 - 2 of 2 items for

  • Author: R Takayanagi x
  • Refine by access: All content x
Clear All Modify Search
T Okabe
Search for other papers by T Okabe in
Google Scholar
PubMed
Close
,
R Takayanagi
Search for other papers by R Takayanagi in
Google Scholar
PubMed
Close
,
M Adachi
Search for other papers by M Adachi in
Google Scholar
PubMed
Close
,
K Imasaki
Search for other papers by K Imasaki in
Google Scholar
PubMed
Close
, and
H Nawata
Search for other papers by H Nawata in
Google Scholar
PubMed
Close

Nur77 is a member of the steroid receptor superfamily and is known to be expressed in animals under stress. We studied the role of nur77 in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis during the stress response using a murine pituitary corticotrope cell line, AtT-20. Corticotropin-releasing hormone (CRH), a stress mediator in the HPA axis, induced the expression of nur77 transiently in AtT-20 cells. Gel shift assay showed that nur77 bound to negative glucocorticoid responsive element (nGRE) in the promoter of the human proopiomelanocortin (POMC) gene and the formation of the nur77-nGRE complex increased after treatment of the cells with CRH. Negative GRE is known to be necessary for the negative regulation by glucocorticoid of the POMC gene expression. In stable transformants of AtT-20 cells expressing a human homolog of nur77, NAK-1, at a high level, glucocorticoid-mediated inhibition of both POMC mRNA induction and ACTH secretion was significantly lower than that in the NAK-1-non-expressing cells (P < 0.001). These results strongly suggest that nur77 antagonizes the negative feedback effect of glucocorticoid on the synthesis and secretion of ACTH in pituitary corticotropes. This suggests that nur77 plays an important role in the pituitary gland in the biological adaptation to overcome stress.

Free access
Y. Nishi
Search for other papers by Y. Nishi in
Google Scholar
PubMed
Close
,
M. Haji
Search for other papers by M. Haji in
Google Scholar
PubMed
Close
,
S. Tanaka
Search for other papers by S. Tanaka in
Google Scholar
PubMed
Close
,
T. Yanase
Search for other papers by T. Yanase in
Google Scholar
PubMed
Close
,
R. Takayanagi
Search for other papers by R. Takayanagi in
Google Scholar
PubMed
Close
,
Y. Etoh
Search for other papers by Y. Etoh in
Google Scholar
PubMed
Close
, and
H. Nawata
Search for other papers by H. Nawata in
Google Scholar
PubMed
Close

ABSTRACT

The effect of human recombinant activin-A on adrenal steroidogenesis was studied in cultured bovine adrenocortical cells. Activin-A significantly reduced cortisol output from ACTH (10nmol/l)-stimulated adrenocortical cells incubated for 24 hours in a dose-dependent manner (10, 100 and 500ng activin-A /ml suppressed cortisol secretion by 19, 33 and 40%), although no significant effect was observed in the case of 3 h incubation. Dehydroepiandrosterone (DHEA) secretion from ACTH-stimulated adrenocortical cells incubated for 24 h was also decreased by the addition of activin-A in a dose-dependent manner. (10, 100 and 500ng activin-A /ml suppressed DHEA secretion by 22, 56 and 58%).

These inhibitory effects of activin-A (100ng/ml) on cortisol and DHEA secretion were partially blocked by the addition of follistatin / FSH-Suppressing Protein (200ng/ml). In contrast, activin-A treatment resulted in no significant decrease in aldosterone secretion. There were no significant effects of activin-A on basal secretions of cortisol, DHEA or aldosterone from adrenocortical cells. These results suggest that activin-A has a direct inhibitory effect on ACTH-stimulated bovine adrenocortical steroidogenesis.

Restricted access